
Jonathan S. Lau
Examiner (ID: 8893, Phone: (571)270-3531 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1623, 1673 |
| Total Applications | 1249 |
| Issued Applications | 700 |
| Pending Applications | 107 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19462413
[patent_doc_number] => 20240316082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/598608
[patent_app_country] => US
[patent_app_date] => 2024-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18598608
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/598608 | MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION | Mar 6, 2024 | Pending |
Array
(
[id] => 19447297
[patent_doc_number] => 20240307427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => REMDESIVIR COCRYSTAL, COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/594986
[patent_app_country] => US
[patent_app_date] => 2024-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18594986
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/594986 | REMDESIVIR COCRYSTAL, COMPOSITIONS AND METHODS THEREOF | Mar 3, 2024 | Pending |
Array
(
[id] => 20206276
[patent_doc_number] => 20250275996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => COMBINATION OF TUNICAMYCIN-TYPE ANTIBIOTIC WITH POLYMYXINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/591513
[patent_app_country] => US
[patent_app_date] => 2024-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18591513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/591513 | COMBINATION OF TUNICAMYCIN-TYPE ANTIBIOTIC WITH POLYMYXINS AND USES THEREOF | Feb 28, 2024 | Pending |
Array
(
[id] => 20817613
[patent_doc_number] => 12673067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-07
[patent_title] => Methods, agents, and devices for local neuromodulation of autonomic nerves
[patent_app_type] => utility
[patent_app_number] => 18/444468
[patent_app_country] => US
[patent_app_date] => 2024-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23020
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18444468
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/444468 | Methods, agents, and devices for local neuromodulation of autonomic nerves | Feb 15, 2024 | Issued |
Array
(
[id] => 19360820
[patent_doc_number] => 20240262854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Process for Preparing Imetelstat
[patent_app_type] => utility
[patent_app_number] => 18/435848
[patent_app_country] => US
[patent_app_date] => 2024-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435848
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/435848 | Process for preparing imetelstat | Feb 6, 2024 | Issued |
Array
(
[id] => 19536773
[patent_doc_number] => 12129314
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-10-29
[patent_title] => Ultrasound-assisted method for high-yield cellulose extraction from raw rice straw without the need for bleaching step
[patent_app_type] => utility
[patent_app_number] => 18/429102
[patent_app_country] => US
[patent_app_date] => 2024-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2801
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18429102
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/429102 | Ultrasound-assisted method for high-yield cellulose extraction from raw rice straw without the need for bleaching step | Jan 30, 2024 | Issued |
Array
(
[id] => 19402146
[patent_doc_number] => 20240285657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => VETERINARY FORMULATION OF METRONIDAZOLE, AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/424367
[patent_app_country] => US
[patent_app_date] => 2024-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424367
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/424367 | VETERINARY FORMULATION OF METRONIDAZOLE, AND RELATED METHODS | Jan 25, 2024 | Pending |
Array
(
[id] => 19722741
[patent_doc_number] => 20250025492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/421551
[patent_app_country] => US
[patent_app_date] => 2024-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18421551
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/421551 | DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS | Jan 23, 2024 | Pending |
Array
(
[id] => 19188173
[patent_doc_number] => 20240167086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => NUCLEOSIDE-5'-OLIGOPHOSPHATES HAVING A CATIONICALLY-MODIFIED NUCELOBASE
[patent_app_type] => utility
[patent_app_number] => 18/542500
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18542500
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/542500 | NUCLEOSIDE-5'-OLIGOPHOSPHATES HAVING A CATIONICALLY-MODIFIED NUCELOBASE | Dec 14, 2023 | Pending |
Array
(
[id] => 19638073
[patent_doc_number] => 12168674
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-17
[patent_title] => Reagents and methods for the highly-efficient synthesis and purification of biopolymers
[patent_app_type] => utility
[patent_app_number] => 18/534413
[patent_app_country] => US
[patent_app_date] => 2023-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 16
[patent_no_of_words] => 14819
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18534413
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/534413 | Reagents and methods for the highly-efficient synthesis and purification of biopolymers | Dec 7, 2023 | Issued |
Array
(
[id] => 19216206
[patent_doc_number] => 20240180910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => METHOD FOR TREATING CANCER WITH A CHEMOTHERAPEUTIC MODIFIER
[patent_app_type] => utility
[patent_app_number] => 18/529271
[patent_app_country] => US
[patent_app_date] => 2023-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18529271
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/529271 | METHOD FOR TREATING CANCER WITH A CHEMOTHERAPEUTIC MODIFIER | Dec 4, 2023 | Pending |
Array
(
[id] => 19201448
[patent_doc_number] => 20240173347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => COMPOSITIONS FOR RAISING NAD LEVELS AND METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/522970
[patent_app_country] => US
[patent_app_date] => 2023-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18522970
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/522970 | COMPOSITIONS FOR RAISING NAD LEVELS AND METHODS AND USES THEREOF | Nov 28, 2023 | Pending |
Array
(
[id] => 19170884
[patent_doc_number] => 20240156858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Treatment of Bone Marrow Edema (Oedema) With Polysulfated Polysaccharides
[patent_app_type] => utility
[patent_app_number] => 18/515823
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18515823
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/515823 | Treatment of Bone Marrow Edema (Oedema) With Polysulfated Polysaccharides | Nov 20, 2023 | Pending |
Array
(
[id] => 20608356
[patent_doc_number] => 12583945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 18/512798
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 3056
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512798
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/512798 | Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof | Nov 16, 2023 | Issued |
Array
(
[id] => 19998745
[patent_doc_number] => 20250136967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => REME-D NUCLEIC ACID EXTRACTION KITS
[patent_app_type] => utility
[patent_app_number] => 18/498571
[patent_app_country] => US
[patent_app_date] => 2023-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18498571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/498571 | REME-D NUCLEIC ACID EXTRACTION KITS | Oct 30, 2023 | Pending |
Array
(
[id] => 19156171
[patent_doc_number] => 20240148878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => THERAPEUTIC POLY-ADP-RIBOSE POLYMER-GCSF CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 18/493223
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493223
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/493223 | THERAPEUTIC POLY-ADP-RIBOSE POLYMER-GCSF CONJUGATES | Oct 23, 2023 | Pending |
Array
(
[id] => 19216243
[patent_doc_number] => 20240180947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => LYOPHILIZED FORMULATIONS OF CD73 COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/490434
[patent_app_country] => US
[patent_app_date] => 2023-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490434
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/490434 | LYOPHILIZED FORMULATIONS OF CD73 COMPOUNDS | Oct 18, 2023 | Pending |
Array
(
[id] => 19248685
[patent_doc_number] => 20240199672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => Process for Preparing Imetelstat
[patent_app_type] => utility
[patent_app_number] => 18/487919
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18487919
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/487919 | Process for Preparing Imetelstat | Oct 15, 2023 | Abandoned |
Array
(
[id] => 19387878
[patent_doc_number] => 20240277748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
[patent_app_type] => utility
[patent_app_number] => 18/379047
[patent_app_country] => US
[patent_app_date] => 2023-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379047
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379047 | VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | Oct 10, 2023 | Pending |
Array
(
[id] => 18970364
[patent_doc_number] => 20240050456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
[patent_app_type] => utility
[patent_app_number] => 18/482334
[patent_app_country] => US
[patent_app_date] => 2023-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18482334
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/482334 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES | Oct 5, 2023 | Pending |